Submissions

Login or Register to make a submission.

Author Guidelines

Contents

Journal scope

Biomolecules and Biomedicine (formerly the Bosnian Journal of Basic Medical Sciences, BJBMS) is a comprehensive, multidisciplinary open-access medical journal dedicated to the advancement of medical research, practice, and education. The journal publishes pioneering research across the spectrum of pre-clinical studies, translational medicine, and clinical research, thereby advancing our collective knowledge in the realm of health and disease.Top of page ⤴

Article types

Biomolecules and Biomedicine considers the following article types. Authors should select the category that best fits their work. The Editors may reclassify a submission if deemed more appropriate.

1. Special article (Guideline, Statement article, Opinion article)

Special articles are usually invited, but high-quality unsolicited manuscripts may be considered.

  • Scope: Clinical or methodological guidelines, position/consensus statements, or opinion pieces on topics relevant to biomolecular and biomedical research and practice.
  • Content: Clear description of the problem, rationale, and implications for practice, policy, or research.
  • Guidelines/Statements: Should describe the methodology for evidence review and consensus (where applicable), and clearly present recommendations or key messages.
  • Opinion articles: Should be balanced, evidence-informed, and clearly distinguished as opinion/interpretation rather than original data.

2. Review

Reviews provide a comprehensive, balanced, and critical overview of a specific topic.

  • Scope: Narrative or focused reviews on clinically and/or biologically relevant subjects, highlighting recent advances, controversies, and knowledge gaps.
  • Content: Clear objectives, structured synthesis of the literature, critical appraisal (not just a descriptive summary), and a section on future directions.
  • Data: No new, previously unpublished primary data should be included, except illustrative examples clearly labeled as such.

3. Research article

Research articles present original research findings.

  • Scope: Clinical, translational, experimental, methodological, or population-based studies.
  • Structure: IMRaD format (Introduction, Methods, Results, Discussion), with clear hypotheses/objectives, transparent methods, and robust statistics.
  • Requirements: Ethics approval and informed consent statements where applicable, clear description of study design, sample size, statistical analysis, and a data availability statement where relevant.

4. Systematic review / Meta-analysis

Systematic reviews and meta-analyses should follow established methodological standards.

  • Scope: Quantitative or qualitative syntheses that address a clearly formulated question using systematic, reproducible methods.
  • Standards: Strongly encouraged to follow PRISMA (and PRISMA-P for protocols). Registration of the review protocol in a public registry (e.g., PROSPERO) is recommended and should be stated.
  • Content: Search strategy, inclusion/exclusion criteria, study selection process, risk-of-bias assessment, data extraction, and synthesis methods must be fully described.
  • Meta-analysis: Effect sizes and heterogeneity measures should be reported with appropriate sensitivity analyses.

5. Video article

Video articles combine a concise written manuscript with a high-quality video component.

  • Scope: Procedural techniques, laboratory methods, imaging protocols, or other visually driven content that benefits from dynamic demonstration.
  • Content: Short text describing background, indications, step-by-step methods, and key pitfalls, plus a video file with clear narration or subtitles in English.
  • Patient data: Any patient-identifiable information must be removed or fully anonymized; explicit consent is required when patients are visible or identifiable.
  • Technical details: File formats, size limits, and resolution requirements are provided on the journal’s website and must be followed.

6. Short communication

Short communications are brief reports of original findings that merit rapid dissemination.

  • Scope: Novel preliminary findings, concise clinical or methodological observations, or secondary analyses of high interest.
  • Content: Focused text with a clear single message, limited number of tables/figures, and succinct discussion.
  • Data: Methods and statistics must still be described with sufficient detail to allow interpretation and, where possible, replication.

7. Letter to the editor

Letters provide a forum for scientific dialogue and constructive critique.

  • Scope: Comments on articles recently published in Biomolecules and Biomedicine, or short observations, hypotheses, or clarifications relevant to the journal’s scope.
  • Content: Objective, respectful tone with a clear main point. For letters about a published article, authors of that article may be invited to respond.
  • Limitations: Typically short text with a restricted number of references and no or minimal figures/tables (see detailed Instructions for Authors).

8. Case report with a literature review

Case-based manuscripts must provide more than a simple description of a rare event.

  • Scope: Single or small series of cases that illustrate novel or rare presentations, diagnostic challenges, therapeutic approaches, or mechanisms, and are contextualized within a focused literature review.
  • Structure: Introduction, detailed case description(s), discussion integrating a concise but critical review of the literature, and clear learning points or practice implications.
  • Requirements: Written informed consent from the patient(s) or legal guardian(s) and appropriate ethics considerations, with sufficient clinical, imaging, and/or pathological detail to support the conclusions.

9. Commentary

Commentaries provide expert perspective on a specific article or topic.

  • Scope: Usually invited, focusing on articles recently published in Biomolecules and Biomedicine or on emerging concepts, policy issues, or methodological developments.
  • Content: Concise, scholarly discussion that places the topic in a broader context and offers a critical but constructive perspective.
  • Conflict of interest: Any potential conflicts, including involvement in related studies or guidelines, must be transparently declared.

Top of page ⤴

Article submission

Before submission

1. Prepare the author information and cover letter.

Author information: Full names, email addresses, and ORCID iDs of all co-authors in the manuscript. All the authors will receive an email to link their ORCID iD with the submission. See here why the ORCID iD is important and why it should be used. 

Include the following information in your cover letter:

  • An explanation of why your manuscript should be published in Biomolecules and Biomedicine.
  • An explanation of any issues relating to journal policies
  • A declaration of any potential competing interests.
  • Peer reviewers. You may suggest or exclude potential peer reviewers for your manuscript. If you wish to do so, please provide institutional email addresses where possible, or information which will help the Editor to verify the identity of the reviewer (for example, an ORCID or Scopus ID). Intentionally falsifying information, for example, suggesting reviewers with a false name or email address, will result in rejection of your manuscript and may impact future submissions.
  • If you have previously served as a peer-reviewer for Biomolecules and Biomedicine, you are entitled to Benefits for reviewers. Provide the submission numbers or titles of the manuscripts you reviewed to get an APC discount.
  • We welcome preprints; please indicate if the article has been previously shared as a preprint.

2. Prepare the manuscript according to Manuscript preparation guidelines.
3. Prepare the figures files (if applicable).
4. Understand the costs and funding options for publishing in Biomolecules and Biomedicine.

Manuscript preparation

Scientific writing and English language

Before submitting, check your manuscript with https://www.goodreports.org/ made by the EQUATOR Network writing guidelines. The guidelines may be found at http://www.equator-network.org/. Using the appropriate guidelines when writing your manuscript improves the quality of the manuscript significantly and improves the chance for publication. Another tool called www.penelope.ai may also be helpful in the initial screening of completeness of your manuscript. Also, reviewing previously published articles in the Current Issue is useful to familiarize yourself with the structuring requirements of Biomolecules and Biomedicine.

The manuscripts have to conform to standard scientific English language style, grammar, and clarity. Authors who feel that their manuscript may benefit from additional academic writing or language editing support before submission are encouraged to seek out such services at their host institutions, engage with colleagues and subject matter experts, and/or consider professional English language editing vendors. Clearly, well-written manuscripts have a much better chance of acceptance.

Accepted manuscripts are subject to evaluation of the quality of English language and scientific writing. Manuscripts deemed requiring significant improvement of the language or writing will be returned to authors for corrections. If the corrections do not meet standards for publication, authors are advised to refer to experienced companies that provide professional language editing services.

Formatting

Download and use the formatted Biomolecules and Biomedicine manuscript template to avoid formatting errors. 

BiomolBiomed manuscript template

The main manuscript file must include the following sections:

  • Title page
  • Abstract and Keywords
  • Text
  • Acknowledgements (if applicable)
  • Declaration of interest
  • References
  • Tables
  • Figures with figure legends

Abbreviations and symbols

Abbreviations should be defined on their first appearance in the text; those not accepted by international bodies should be avoided. Use only standard abbreviations. Avoid abbreviations in the title and abstract.

Title page

The title of the manuscript should not be longer than 15 words. Provide the full first and last names of the authors and their institutions, as well as the corresponding author's address and email. Note that when submitting the manuscript, the e-mails of all the authors have to be provided in the online submission process. 

Abstract

The second page should carry an abstract of about 250 words, except for Letters to the Editor and Commentaries. The abstract should not be structured, i.e., it should not contain subheadings; nevertheless, it should state the objective(s) of the study or investigation, basic methods (selection of study subjects or laboratory animals; observational and analytical methods), main results (giving specific data and their statistical significance, if possible), and the principal conclusions. It should emphasize new and important aspects of the study or observations.

Keywords

The abstract should be followed by a list of 3 to 10 keywords or short phrases that will assist in the cross-indexing of the article and which may be published. When possible, the terms used should be from the Medical Subject Headings list of the National Library of Medicine (http://www.nlm.nih.gov/mesh/meshhome.html).

Text

Original research articles should have standard sections headed: Introduction, Materials and Methods (including ethical and statistical information), Results, Discussion, and Conclusion, although reviews may have a different format.
Text file size can not exceed 5 MB.

Tables

Provide the tables at the end of the manuscript. Number the tables according to their sequence in the text. The text should include references to all the tables. Each table should be assigned an Arabic numeral, e.g., (Table 3). Include a brief and self-explanatory title with explanations essential to the understanding of the table at the bottom of the table. Identify statistical measures of variations, such as standard deviation and standard error of the mean, or other where appropriate.

Figures

References to figures and tables should be made in order of appearance in the text and should be in Arabic numerals in parentheses, e.g., (Figure 2). Line art should be at a resolution of 600 dpi, and halftones and color at 300 dpi. Figures should be presented to a width of about 80 mm (one column) or, when the illustration demands it, to a width of about 160 mm. If photographs of people are used, their identities must be obscured, or the picture must be accompanied by written consent to use the photograph. If a figure has been published before, the source must be acknowledged, and written permission from the copyright holder for both print and electronic formats should be submitted with the material. Permission is required regardless of authorship or publisher, except for documents in the public domain. Figures may be reduced, cropped, or deleted at the discretion of the editor. Figure file size can not exceed 5 MB. For more information, see the figure guidelines.

Blot and gel reporting requirements

Biomolecules and Biomedicine imposes the following quality and transparency policies for blot and gel image results to ensure the integrity and scientific validity of blot/gel data reporting.

The authors have to provide original, uncropped, unadjusted, or otherwise manipulated images during the peer review process or before the manuscript is accepted. The authors will be contacted by the Editorial office to provide the images by email, or if the files are large, using an appropriate file transfer service.

For more details on the original blot and gel images and reporting the blot/gel results, please consult the PLOS ONE Blot and Gel Reporting Requirements on which the Biomolecules and Biomedicine policies were built. 

Randomized Controlled Trial (RTC) registration requirements

For manuscripts reporting results from Randomized Controlled Trials (RCTs), registration in a publicly accessible registry is mandatory prior to submission. Authors must provide the trial registration number from a recognized repository, such as the World Health Organization's International Clinical Trials Registry Platform (ICTRP) or ClinicalTrials.gov, in accordance with the International Committee of Medical Journal Editors (ICMJE) guidelines.  An acceptable registry must include the minimum 24-item trial registration data set.

Manuscripts lacking trial registration may be rejected without further review.

Units of measurement

Measurements of length, height, weight, and volume should be reported in metric units (meter, kilogram, or liter) or their decimal multiples. All hematologic and clinical chemistry measurements should be reported in the metric system in terms of the International System of Units (SI).

References

References should be numbered consecutively in the order in which they first appear in the text. They should be assigned Arabic numerals, which should be given in brackets, e.g., [17]. References should include the names of all authors when there are six or fewer; when there are seven or more, list only the first six names and add et al. References should also include the full title and source information (Vancouver style). Journal names should be abbreviated as in MEDLINE.

For detailed information about how to cite different sources see: CITING MEDICINE, 2nd edition: The NLM Style Guide for Authors, Editors, and Publishers 

Standard journal article

Tashiro H, Shimokawa H, Sadamatu K, Yamamoto K. Prognostic significance of plasma concentrations of transforming growth factor-beta in patients with coronary artery disease. Coron Artery Dis 2002;13(3):139-143.

More than six authors

Yetkin E, Senen K, Ileri M, Atak R, Tandogan I, Yetkin Ö, et al. Comparison of low-dose dobutamine stress echocardiography and echocardiography during glucose-insulin-potassium infusion for detection of myocardial viability after anterior myocardial infarction. Coron Artery Dis 2002;13(3):145-149.

Books

Heger JW, Niemann JT, Criley JM. Cardiology, 5th ed. Philadelphia: Lippincott, Williams & Wilkins; 2003.

Chapter in a book

Braunwald E, Perloff JK. Physical examination of the heart and circulation. In; Braunwald E, Zipes DP, Libby P (eds). Heart disease; a textbook of cardiovascular medicine, 6th ed. Philadelphia: WB Saunders; 2001, pp. 45–81.

Personal communications and unpublished work should not appear in the reference list but should appear in parentheses in the text. Unpublished work accepted for publication but not yet released should be included in the reference list with the words 'in press' in parentheses beside the name of the journal concerned. References must be verified by the author(s) against the original documents. Top of page ⤴

Submitting the article

1. REGISTER or LOG IN at Biomolecules and Biomedicine website
2. Follow the multistep process to enter information and upload files. Top of page ⤴

After submission

Peer review

Once a manuscript is submitted, it is assigned to the Editor most appropriate to handle it, based on the subject of the manuscript and the availability of the Editors. If the Editor determines that the manuscript is not of sufficient quality to go through the normal review process or if the subject of the manuscript is not appropriate to the journal's scope, the Editor rejects the manuscript with no further processing. This decision is made within 1–3 days.

If the Editor determines that the submitted manuscript is of sufficient quality and falls within the scope of the journal, he/she assigns the manuscript to a minimum of 2 and a maximum of 5 external reviewers for peer-review. The reviewers submit their reports on the manuscripts along with their recommendation of one of the following actions to the Editor:

Accept submission
Minor Revisions required
Major Revisions
Decline submission

When all reviewers have submitted their reports, the Editor can make one of the following decisions: Publish Unaltered, Consider after Minor Changes, Consider after Major Changes, Reject. This decision is usually made within 30 days from the submission date.

If the Editor recommends "Publish Unaltered," the manuscript is accepted for publication. The manuscript is then assigned a DOI number and is published within 2 days in the Advance online section of the Journal and in PubMed.

If the Editor recommends "Consider after Minor Changes," the authors are notified to prepare and submit a final copy of their manuscript with the required minor changes suggested by the reviewers. The Editor reviews the revised manuscript after the minor changes have been made by the authors. Once the Editor is satisfied with the final manuscript, the manuscript can be accepted. The revised manuscript has to be submitted within two weeks. If you think you are unable to meet the deadline, please notify the Editorial Office.

If the Editor recommends "Consider after Major Changes," the recommendation is communicated to the authors. The authors are expected to revise their manuscripts in accordance with the changes recommended by the reviewers and to submit their revised manuscript within three months. Submission later than that will be regarded as a new submission that will go through the complete review process from the beginning. If you think you are unable to meet the deadline, please notify the Editorial Office.

If the Editor recommends rejecting the manuscript, the rejection is immediate. Also, if two of the reviewers recommend rejecting the manuscript, the rejection is immediate. The editorial workflow gives the Editors the authority to reject any manuscript because of the inappropriateness of its subject, lack of quality, or incorrectness of its results. The Editor cannot assign himself/herself as an external reviewer of the manuscript. This is to ensure a high-quality, fair, and unbiased peer-review process of every manuscript submitted to the journal, since any manuscript must be recommended by one or more (usually two or more) external reviewers along with the Editor in charge of the manuscript in order for it to be accepted for publication in the journal.

The peer-review process is double-blinded, i.e., the reviewers do not know who the authors of the manuscript are and the authors do not have access to the information of who the peer-reviewers are. Without the significant contributions made by peer reviewers, the publication of the journal would not be possible.

Revision and response to reviewers

The authors should provide a detailed response letter; please copy-paste each of the reviewer's comments and provide specific responses to them. The authors must specify which changes were made in the manuscript and highlight the changes in the revised manuscript file. General statements (e.g., "comment accepted", "discussion corrected") should be avoided. The response letter should be written in such a manner that the responses could be forwarded to reviewers without prior editing.Top of page ⤴

Withdrawal of the manuscripts

In accordance with our commitment to facilitate a seamless and efficient publication process, authors are allowed to withdraw their manuscript from consideration without the need to provide a justification within the initial 24 hours following submission. This policy is designed to accommodate immediate reconsiderations and unforeseen circumstances that may lead an author to retract their submission promptly. However, should authors decide to withdraw their manuscript after this 24-hour period we require a detailed explanation outlining the valid reasons for such a decision. This stipulation ensures transparency and aids in the continuous improvement of our editorial practices, while also respecting the significant effort and resources allocated to the manuscript's review process. Authors are encouraged to communicate their intentions and the rationale for withdrawal with clarity and professionalism, adhering to the ethical standards of scientific publishing.

After acceptance

Article processing fees

Articles published in the Biomolecules and Biomedicine are Open Access and freely available online immediately upon publication. This is made possible by an article-processing charge (APC) that covers the cost of maintenance of the tools for editors and authors, article production and hosting, liaison with abstracting and indexing services, and other editorial services.

See the article processing fees here.

Institutional Open Access Membership Program (IOAMP)

This program allows APC discounts if the corresponding author's institution participates in our Institutional Open Access Membership Program. Partial or all of the publication costs may be covered by the author's institution at a reduced APC (more details are available at the IOAMP page). Top of page ⤴

Author summary guidelines

What is the Author Summary?

The Author Summary is 200-250 words non-technical summary of the research, for non-expert readers.

What are the aims of the Author Summary?

The Author Summary is aimed to make the findings more accessible and available to a wide audience, but also to increase the readership of an article. Therefore, we require that authors of accepted articles write a short non-technical summary of their research for non-expert readers. We also ask the authors to provide their photo, or a photo of their research group, or a photo of their institution. If the authors do not want their photo to be published, the figure from their article may be used, or the appropriate illustration chosen by the Blog Editor.

Where will the Author Summary be published?

The Author summary will be published at the Journal’s BLOG (blog.bjbms.org), our social media, and sent to web-based medical news services (e.g. medicalxpress.com, phys.org). This will significantly improve the visibility of the article and the authors.

See the Author summary guidelines here.

Video summary guidelines

Instead of the usual text-only Author Summary, we introduced an additional way to present the research findings to our readers and followers - using a Video Summary.

Basically, the same principles and guidelines apply as for the Author Summary. The only difference is that the summary is presented in video form.

Click here to see the Video Summary guidelines.

Corrections and retractions

To notify Biomolecules and Biomedicine of an error in your publication that warrants correction or retraction, please email the journal (office@bjbms.org) with the relevant details (article citation and DOI, description of the error), the proposed correction text, and any supporting files. Post-publication notices are assigned DOIs and linked to the affected articles.

Author Correction (Corrigendum). Notification by the author(s) of a significant error that affects the publication record or the scientific integrity of the work, or the reputation of the authors or the journal. For corrections pertaining to the article's results, please include supplementary files with the underlying raw data supporting the results in question. The same policy applies if an authorship correction is required in a published paper, e.g., authors who've changed their names. Corrigenda require a separate APC. For more information, see the APC section.

Retraction. All co-authors must sign a retraction indicating the error and briefly explaining how the conclusions are affected and submit it for publication. In cases where co-authors disagree, internal editors may seek the advice of independent reviewers and enforce the type of change they deem most appropriate, with mention of the dissenting author(s) in the text of the published version.

Top of page ⤴

Most Cited Paper Award

Biomolecules and Biomedicine awards the Most Cited Paper Award to honor outstanding contributions that have made a significant impact on the scientific community.

About the Award

The Most Cited Paper Award is granted annually to the article published in Biomolecules and Biomedicine that has received the highest number of citations according to Dimensions. This award reflects our commitment to promoting high-quality research with meaningful influence on the field of biomedicine and molecular science.

The award is presented each February to honor the most cited article published three years earlier; for example, in 2026, the award will recognize the most cited article from 2023.

Eligibility Criteria

All original research articles and review papers published in Biomolecules and Biomedicine in a certain year are automatically eligible.

No application or nomination is required.

Citation counts will be based on data from Dimensions, assessed as of February, 2026. In case of a tie in citation count, the award will be granted to the paper with the higher Relative Citation Ratio.

Editorials, letters and case reports are excluded from eligibility.

Award Components

  • Digital Award Certificate
  • Featured profile and interview on our website and social media platforms
  • Highlight on the journal homepage and newsletter
  • Waiver of Article Processing Charges (APC) for one future publication in Biomolecules and Biomedicine
  • Custom digital badge for use on LinkedIn, ORCID, ResearchGate, and institutional websites
  • Official notification letter sent to the awardee’s affiliated institution, acknowledging and celebrating the achievement

Each year a list of the Top 5 Most Cited Papers will be published. These articles will be recognized on our website.

Submission Preparation Checklist

By submitting the manuscript you accept or confirm the following:

  • I read the Author guidelines for pre-submission requirements.
  • The manuscript is well written, accurate, and readable (see the Author Guidelines for Scientific writing and language editing)
  • I downloaded and used the Biomolecules and Biomedicine Manuscript template file to ensure the manuscript follows the formatting guidelines.
  • I included figures and tables at the end of the main manuscript file; I will provide original, high-resolution versions when requested by the editorial office.
  • Maximum file size for upload is 5 MB, for each file. If you need to upload larger files, such as video, please contact us office@biomolbiomed.com.
  • I understand the cost of publishing and funding options (see Article processing fee)
  • I accept the Copyright Policy of this journal.
  • I accept the Editorial Policy of this journal.
  • I confirm that the content of this manuscript has not been published, or currently submitted for publication elsewhere (except at conference or as pre-print, which is noted in the cover letter)
  • I confirm that all the authors have approved the manuscript for submission.

Special Article

 

 

 

Review

 

 

 

Short Communication

 

 

 

Video Article

 

 

 

Case Report with review

 

 

 

Letter to the Editor

 

 

 

Comment

 

 

 

Copyright Notice

Biomolecules and Biomedicine applies the Creative Commons Attribution (CC-BY) license to published articles. Under this license, authors retain ownership of the copyright for their content, but they allow anyone to download, reuse, reprint, modify, distribute and/or copy the content as long as the original authors and source are cited. Appropriate attribution can be provided by simply citing the original article.

Privacy Statement

We respect and protect your privacy. This statement describes the types of personal information we collect from authors, reviewers, readers, and other visitors to our journal website, how we use and safeguard that information, and the choices you have regarding your personal data.

Information we collect

  1. contact details: We may collect names, institutional affiliations, email addresses, and postal addresses, particularly from authors and reviewers, to manage submissions, peer review activities, and correspondence.
  2. manuscript and publication data: Submitted articles, supplementary materials, and peer review reports may contain personal information, including author affiliations and acknowledgments.
  3. website usage data: When you visit our website, we may automatically collect information related to your browser type and IP address. This data helps us understand how our website is used and improve user experience.

How we use personal information

  1. manuscript handling: Author and reviewer details are used to manage editorial and publishing processes, including peer review and communications related to submissions and accepted articles.
  2. communications and updates: We may use your contact information to send important updates regarding your submission, journal news, policy changes, and related announcements.
  3. website improvement: Aggregate, non-identifiable website usage data helps us improve site navigation, functionality, and content relevance.
  4. legal compliance: We may use personal information to comply with applicable laws and regulations, or respond to lawful requests and legal proceedings.

Data sharing and disclosure

  1. with service providers: We may share personal information with trusted third-party service providers who assist in journal operations (e.g., manuscript tracking systems, website hosting, digital archiving services). These providers are contractually obligated to protect your data and use it only for authorized purposes.
  2. with academic databases and indexing services: Author and publication details may be shared with indexing and archiving services to enhance visibility and discoverability of published work.
  3. legal and regulatory reasons: We may disclose personal information if required by law, regulation, or to protect the rights, property, or safety of the journal, its users, or the public.

Data security and retention

We maintain appropriate technical and organizational measures to protect personal data against loss, unauthorized access, disclosure, alteration, or destruction. Personal information is retained as long as necessary for the purposes described in this statement and as required by applicable laws and regulations.

Cookies and similar technologies

We may use cookies and similar technologies to improve the user experience. Cookies help remember user preferences, maintain sessions, and gather site analytics. Most browsers allow you to control or disable cookies through your settings; however, disabling cookies may limit certain website functionalities.

Your rights and choices

You have the right to request access to your personal data, correct inaccuracies, or request deletion. To exercise these rights or if you have questions about how we handle your data, please contact us at the email address provided below.

Changes to this privacy statement

We may update this privacy statement from time to time to reflect changes in our practices, legal requirements, or services. Any updates will be posted on this page with a revised effective date.

Contact us

If you have questions, concerns, or requests regarding this privacy statement or our data handling practices, please contact us at office@biomolbiomed.com

Revised: January 2025